USA - NASDAQ:AGRX - US00847L3087 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to AGRX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-18 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-09-22 | Maxim Group | Upgrade | Hold -> Buy |
| 2023-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2022-12-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-26 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-08 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-11-03 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-27 | RBC Capital | Maintains | Outperform |
7 analysts have analysed AGRX and the average price target is 5.1 USD. This implies a price increase of 746.89% is expected in the next year compared to the current price of 0.6022.
The consensus rating for AGILE THERAPEUTICS INC (AGRX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.